Bayer has delayed a planned sale of its animal health unit to private equity interests in order to explore a merger with US firm Elanco, claims Reuters. Citing three separate anonymous sources ...
The rumoured sale of Bayer’s animal health unit to Elanco has been confirmed as going ahead, with the German company set to make $7.6 billion from the sale. The divestment will make Elanco the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results